|
2024
|
Invention
|
Il-2 muteins and uses thereof.
The present application provides for IL-2 muteins, compositions c... |
|
2022
|
Invention
|
Kidney-glomerular targeted immunotherapy. Methods and compounds for conferring kidney-glomerular-... |
|
|
Invention
|
Pd-1 antibodies, polypeptides and uses thereof.
Polypeptides for binding to PD-1 and composition... |
|
|
Invention
|
Pd-1 antibodies, polypeptides and uses thereof. Polypeptides for binding to PD-1 and compositions... |
|
|
Invention
|
Pancreas targeted therapeutics and uses thereof.
The disclosure relates to methods and compositi... |
|
|
Invention
|
Pancreas targeted therapeutics and uses thereof. The disclosure relates to methods and compositio... |
|
2021
|
Invention
|
Madcam targeted therapeutics and uses thereof.
Methods and compounds for conferring site-specifi... |
|
|
Invention
|
Madcam targeted therapeutics and uses thereof. Methods and compounds for conferring site-specific... |
|
|
Invention
|
Kidney targeted immunotolerance.
Methods and compounds for conferring kidney-specific immune pri... |
|
|
Invention
|
Skin targeted immunotolerance.
Methods and compounds for conferring skin-specific immune privilege. |
|
|
Invention
|
Skin targeted immunotolerance. Methods and compounds for conferring skin-specific immune privilege. |
|
|
Invention
|
Kidney targeted immunotolerance. Methods and compounds for conferring kidney-specific immune priv... |
|
|
Invention
|
Multi-paratopic anti-pd-1 antibodies and uses thereof.
Multi-paratopic polypeptides that can be ... |
|
|
Invention
|
Multi-paratopic anti-pd-1 antibodies and uses thereof. Multi-paratopic polypeptides that can be u... |
|
|
Invention
|
Il-2 muteins and uses thereof. The present application provides for IL-2 muteins, compositions co... |
|
|
Invention
|
Tissue targeted immunotolerance with pd-1 agonists or il-2 muteins.
Methods and compounds for co... |
|
|
Invention
|
Tissue targeted immunotolerance with pd-1 agonists or il-2 muteins. Methods and compounds for con... |
|
|
Invention
|
Tissue targeted immunotolerance with a cd39 effector. Methods and compounds for conferring site-s... |
|
2020
|
Invention
|
Targeted immunotolerance with a pd-1 agonist.
Methods and polypeptides for conferring site-speci... |
|
|
Invention
|
Madcam targeted immunotolerance. Methods and compounds for conferring site-specific or local immu... |
|
|
Invention
|
Targeted immunotolerance. Methods and compounds for conferring site-specific or local immune priv... |
|
2019
|
Invention
|
Targeted immunotolerance.
Methods and compounds for conferring site-specific or local immune pri... |
|
2018
|
Invention
|
Il-2 muteins and uses thereof. Described herein are therapeutics that can modulate (e.g. increase... |
|
|
Invention
|
Il-2 muteins. The present application provides for IL-2 muteins, compositions comprising the same... |
